AdvanTIG-204: A Phase 2, Randomized, Open-Label Study of Ociperlimab Plus Tislelizumab and Concurrent Chemoradiotherapy Versus Tislelizumab and Concurrent Chemotherapy Versus Concurrent Chemoradiotherapy in First-Line Limited-Stage SCLC. [PDF]
JTO Clin Res RepGong Y +14 more
europepmc +1 more source
Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy
Otolaryngology–Head and Neck Surgery, Volume 174, Issue 2, Page 450-457, February 2026.Abstract Objective To compare cochlear dose and hearing outcomes between intensity‐modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) in patients with nasopharyngeal carcinoma (NPC). Study Design Prospective matched cohorts. Setting Tertiary academic center.
Kuang‐Hsu Lien +11 more
wiley +1 more source
C3-06: ERCC1 expression as a predictive marker in stage IIIA, N2 positive non-small cell lung cancer patients treated with neoadjuvant concurrent chemoradiotherapy followed by surgery [PDF]
, 2007 In Gyu Hwang +12 more
openalex +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 368-376, February 2026.Biopsy‐proven residual tumor at the end of chemoradiation identifies patients at high risk for disease progression. Despite achieving a delayed histologic complete response 6 weeks later, these patients show significantly worse progression‐free survival, suggesting the prognostic value of early tissue‐based response assessment during brachytherapy ...
Christoph Ebner +12 more
wiley +1 more source
Association between pelvic bone marrow dosimetry and acute hematologic toxicity during concurrent chemoradiotherapy for gynecologic malignancies. [PDF]
J Radiat ResZhou C, Chen J.
europepmc +1 more source
Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer [PDF]
, 2013 Sae‐Ryung Kang +14 more
openalex +1 more source
Cancer Science, Volume 117, Issue 2, Page 548-565, February 2026.This study indicates that SPP1, as an important regulator of tumor progression, is upregulated in various tumors and has been associated with a poor prognosis. SPP1+M2 has a unique spatial location at the forefront of tumor invasion and metastasis, thereby promoting tumor progression. MARCO+M2, which forms a mutually exclusive relationship with SPP1+M2,
Xuan Luo +15 more
wiley +1 more source
Predictors of acute and late diarrhea in the treatment of anal cancer with concurrent chemoradiotherapy. [PDF]
Acta OncolStorm KS +8 more
europepmc +1 more source
Long‐term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer [PDF]
, 2017 Jing Zhao +3 more
openalex +1 more source
Cancer Science, Volume 117, Issue 2, Page 429-444, February 2026.The present study revealed for the first time that TGM2 could regulate the radiosensitivity of cervical cancer via POGZ‐mediated DNA DSB repair. Our findings revealed that TGM2 regulates the radiosensitivity of cervical cancer and demonstrated that POGZ serves as a bridge linking TGM2 to the DNA damage repair process, and suggested a novel mechanistic ...
Yunbo Chi +5 more
wiley +1 more source